Benzylsulfonic acid
Star0
Explore a selection of our essential drug information below, or:
Identification
- Generic Name
- Benzylsulfonic acid
- DrugBank Accession Number
- DB03297
- Background
Not Available
- Type
- Small Molecule
- Groups
- Experimental
- Structure
- Weight
- Average: 172.202
Monoisotopic: 172.019414812 - Chemical Formula
- C7H8O3S
- Synonyms
- alpha-Toluenesulfonic acid
- Benzenemethanesulfonic acid
- Benzylsulfinic acid
- Phenylmethanesulfonic acid
- Toluene-alpha-sulphonic acid
Pharmacology
- Indication
Not Available
Reduce drug development failure ratesBuild, train, & validate machine-learning modelswith evidence-based and structured datasets.Build, train, & validate predictive machine-learning models with structured datasets.- Contraindications & Blackbox Warnings
- Prevent Adverse Drug Events TodayTap into our Clinical API for life-saving information on contraindications & blackbox warnings, population restrictions, harmful risks, & more.Avoid life-threatening adverse drug events with our Clinical API
- Pharmacodynamics
Not Available
- Mechanism of action
Target Actions Organism UChymase Not Available Humans USubtilisin BPN' Not Available Bacillus amyloliquefaciens USigma factor SigB regulation protein RsbQ Not Available Bacillus subtilis (strain 168) USuperoxide dismutase [Mn], mitochondrial Not Available Humans USerine protease hepsin Not Available Humans UExtracellular subtilisin-like serine proteinase Not Available Vibrio sp. PA-44 UCarboxylesterase 2 Not Available Pseudomonas fluorescens - Absorption
Not Available
- Volume of distribution
Not Available
- Protein binding
Not Available
- Metabolism
- Not Available
- Route of elimination
Not Available
- Half-life
Not Available
- Clearance
Not Available
- Adverse Effects
- Improve decision support & research outcomesWith structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates. View sample adverse effects data in our new Data Library!Improve decision support & research outcomes with our structured adverse effects data.
- Toxicity
Not Available
- Pathways
- Not Available
- Pharmacogenomic Effects/ADRs
- Not Available
Interactions
- Drug Interactions
- This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.Not Available
- Food Interactions
- Not Available
Categories
- Drug Categories
- Chemical TaxonomyProvided by Classyfire
- Description
- This compound belongs to the class of organic compounds known as benzene and substituted derivatives. These are aromatic compounds containing one monocyclic ring system consisting of benzene.
- Kingdom
- Organic compounds
- Super Class
- Benzenoids
- Class
- Benzene and substituted derivatives
- Sub Class
- Not Available
- Direct Parent
- Benzene and substituted derivatives
- Alternative Parents
- Sulfonyls / Organosulfonic acids / Alkanesulfonic acids / Organic oxides / Hydrocarbon derivatives
- Substituents
- Alkanesulfonic acid / Aromatic homomonocyclic compound / Hydrocarbon derivative / Monocyclic benzene moiety / Organic oxide / Organic oxygen compound / Organic sulfonic acid or derivatives / Organosulfonic acid / Organosulfonic acid or derivatives / Organosulfur compound
- Molecular Framework
- Aromatic homomonocyclic compounds
- External Descriptors
- Not Available
- Affected organisms
- Not Available
Chemical Identifiers
- UNII
- 5BRP81V98H
- CAS number
- 100-87-8
- InChI Key
- NIXKBAZVOQAHGC-UHFFFAOYSA-N
- InChI
- InChI=1S/C7H8O3S/c8-11(9,10)6-7-4-2-1-3-5-7/h1-5H,6H2,(H,8,9,10)
- IUPAC Name
- phenylmethanesulfonic acid
- SMILES
- OS(=O)(=O)CC1=CC=CC=C1
References
- General References
- Not Available
- External Links
- PubChem Compound
- 7532
- PubChem Substance
- 46507289
- ChemSpider
- 7251
- ChEMBL
- CHEMBL1171433
- ZINC
- ZINC000001593155
- PDBe Ligand
- PMS
- PDB Entries
- 1aur / 1eq9 / 1klt / 1pnm / 1s2n / 1sh7 / 1sup / 1v6c / 1wb8 / 1wpr … show 23 more
Clinical Trials
- Clinical Trials
Clinical Trial & Rare Diseases Add-on Data Package
Explore 4,000+ rare diseases, orphan drugs & condition pairs, clinical trial why stopped data, & more. Preview package Phase Status Purpose Conditions Count Start Date Why Stopped 100+ additional columns Unlock 175K+ rows when you subscribe.View sample data
Pharmacoeconomics
- Manufacturers
- Not Available
- Packagers
- Not Available
- Dosage Forms
- Not Available
- Prices
- Not Available
- Patents
- Not Available
Properties
- State
- Solid
- Experimental Properties
- Not Available
- Predicted Properties
Property Value Source Water Solubility 4.35 mg/mL ALOGPS logP -0.97 ALOGPS logP 0.92 Chemaxon logS -1.6 ALOGPS pKa (Strongest Acidic) -0.98 Chemaxon Physiological Charge -1 Chemaxon Hydrogen Acceptor Count 3 Chemaxon Hydrogen Donor Count 1 Chemaxon Polar Surface Area 54.37 Å2 Chemaxon Rotatable Bond Count 2 Chemaxon Refractivity 41.27 m3·mol-1 Chemaxon Polarizability 15.99 Å3 Chemaxon Number of Rings 1 Chemaxon Bioavailability 1 Chemaxon Rule of Five Yes Chemaxon Ghose Filter No Chemaxon Veber's Rule No Chemaxon MDDR-like Rule No Chemaxon - Predicted ADMET Features
Property Value Probability Human Intestinal Absorption + 0.9801 Blood Brain Barrier + 0.9636 Caco-2 permeable - 0.5133 P-glycoprotein substrate Non-substrate 0.8834 P-glycoprotein inhibitor I Non-inhibitor 0.9238 P-glycoprotein inhibitor II Non-inhibitor 1.0 Renal organic cation transporter Non-inhibitor 0.8904 CYP450 2C9 substrate Non-substrate 0.7676 CYP450 2D6 substrate Non-substrate 0.8344 CYP450 3A4 substrate Non-substrate 0.7157 CYP450 1A2 substrate Non-inhibitor 0.8262 CYP450 2C9 inhibitor Non-inhibitor 0.8851 CYP450 2D6 inhibitor Non-inhibitor 0.8646 CYP450 2C19 inhibitor Non-inhibitor 0.8082 CYP450 3A4 inhibitor Non-inhibitor 0.9834 CYP450 inhibitory promiscuity Low CYP Inhibitory Promiscuity 0.8722 Ames test Non AMES toxic 0.7287 Carcinogenicity Carcinogens 0.7078 Biodegradation Not ready biodegradable 0.5111 Rat acute toxicity 2.0676 LD50, mol/kg Not applicable hERG inhibition (predictor I) Weak inhibitor 0.7248 hERG inhibition (predictor II) Non-inhibitor 0.9159
Spectra
- Mass Spec (NIST)
- Not Available
- Spectra
Spectrum Spectrum Type Splash Key Predicted GC-MS Spectrum - GC-MS Predicted GC-MS splash10-0006-9000000000-756370f90e78fee817fc Predicted MS/MS Spectrum - 10V, Positive (Annotated) Predicted LC-MS/MS splash10-0006-9200000000-df02d10baf4ed4437c46 Predicted MS/MS Spectrum - 10V, Negative (Annotated) Predicted LC-MS/MS splash10-00di-0900000000-9e2f120cae1ee234c3d5 Predicted MS/MS Spectrum - 20V, Positive (Annotated) Predicted LC-MS/MS splash10-002f-9000000000-cdee06f3fe5beeb30838 Predicted MS/MS Spectrum - 20V, Negative (Annotated) Predicted LC-MS/MS splash10-00di-0900000000-85002b1bc7bdec1fd247 Predicted MS/MS Spectrum - 40V, Positive (Annotated) Predicted LC-MS/MS splash10-016u-9000000000-0759adfa2196733c0f63 Predicted MS/MS Spectrum - 40V, Negative (Annotated) Predicted LC-MS/MS splash10-0006-9300000000-528fd4285b1f8263104b Predicted 1H NMR Spectrum 1D NMR Not Applicable Predicted 13C NMR Spectrum 1D NMR Not Applicable - Chromatographic Properties
Collision Cross Sections (CCS)
Adduct CCS Value (Å2) Source type Source [M-H]- 135.2694178 predictedDarkChem Lite v0.1.0 [M-H]- 126.98628 predictedDeepCCS 1.0 (2019) [M+H]+ 129.94615 predictedDeepCCS 1.0 (2019) [M+Na]+ 138.89604 predictedDeepCCS 1.0 (2019)
Targets
Build, predict & validate machine-learning models
Use our structured and evidence-based datasets to unlock newinsights and accelerate drug research.
Use our structured and evidence-based datasets to unlock new insights and accelerate drug research.
1. DetailsChymase
- Kind
- Protein
- Organism
- Humans
- Pharmacological action
- Unknown
- General Function
- Major secreted protease of mast cells with suspected roles in vasoactive peptide generation, extracellular matrix degradation, and regulation of gland secretion
- Specific Function
- Endopeptidase activity
- Gene Name
- CMA1
- Uniprot ID
- P23946
- Uniprot Name
- Chymase
- Molecular Weight
- 27324.56 Da
References
2. DetailsSubtilisin BPN'
- Kind
- Protein
- Organism
- Bacillus amyloliquefaciens
- Pharmacological action
- Unknown
- General Function
- Serine-type endopeptidase activity
- Specific Function
- Subtilisin is an extracellular alkaline serine protease, it catalyzes the hydrolysis of proteins and peptide amides. Has a high substrate specificity to fibrin.
- Gene Name
- apr
- Uniprot ID
- P00782
- Uniprot Name
- Subtilisin BPN'
- Molecular Weight
- 39180.935 Da
References
- Kind
- Protein
- Organism
- Bacillus subtilis (strain 168)
- Pharmacological action
- Unknown
- General Function
- Not Available
- Specific Function
- Positive regulator required for energy stress activation of the sigma-B transcription factor. Could be required for RsbP phosphatase activity.
- Gene Name
- rsbQ
- Uniprot ID
- O07015
- Uniprot Name
- Sigma factor SigB regulation protein RsbQ
- Molecular Weight
- 30019.91 Da
References
4. DetailsSuperoxide dismutase [Mn], mitochondrial
- Kind
- Protein
- Organism
- Humans
- Pharmacological action
- Unknown
- General Function
- Destroys superoxide anion radicals which are normally produced within the cells and which are toxic to biological systems
- Specific Function
- Dna binding
- Gene Name
- SOD2
- Uniprot ID
- P04179
- Uniprot Name
- Superoxide dismutase [Mn], mitochondrial
- Molecular Weight
- 24750.015 Da
References
- Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. [Article]
- Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34. [Article]
- Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. [Article]
5. DetailsSerine protease hepsin
- Kind
- Protein
- Organism
- Humans
- Pharmacological action
- Unknown
- General Function
- Serine protease that cleaves extracellular substrates, and contributes to the proteolytic processing of growth factors, such as HGF and MST1/HGFL (PubMed:15839837, PubMed:21875933). Plays a role in cell growth and maintenance of cell morphology (PubMed:21875933, PubMed:8346233). Plays a role in the proteolytic processing of ACE2 (PubMed:24227843). Mediates the proteolytic cleavage of urinary UMOD that is required for UMOD polymerization (PubMed:26673890)
- Specific Function
- Peptidase activity
- Gene Name
- HPN
- Uniprot ID
- P05981
- Uniprot Name
- Serine protease hepsin
- Molecular Weight
- 45011.01 Da
References
- Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. [Article]
- Kind
- Protein
- Organism
- Vibrio sp. PA-44
- Pharmacological action
- Unknown
- General Function
- Serine-type endopeptidase activity
- Specific Function
- Not Available
- Gene Name
- Not Available
- Uniprot ID
- Q8GB52
- Uniprot Name
- Extracellular subtilisin-like serine proteinase
- Molecular Weight
- 55682.135 Da
7. DetailsCarboxylesterase 2
- Kind
- Protein
- Organism
- Pseudomonas fluorescens
- Pharmacological action
- Unknown
- General Function
- Carboxylic ester hydrolase activity
- Specific Function
- Hydrolyzes carboxylic ester bonds with relatively broad substrate specificity.
- Gene Name
- estB
- Uniprot ID
- Q53547
- Uniprot Name
- Carboxylesterase 2
- Molecular Weight
- 23880.115 Da
Drug created at June 13, 2005 13:24 / Updated at June 12, 2020 16:52